← Back to Search

HIL-214 for Gastroenteritis

Phase 2
Waitlist Available
Research Sponsored by HilleVax
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial tests if adults can safely take a pediatric dose of a medication for adults, to make sure it works correctly.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Primary Immunogenicity for Panel Formation

Trial Design

1Treatment groups
Experimental Treatment
Group I: Open Arm StudyExperimental Treatment1 Intervention
One dose given to all participants
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
HIL-214
2023
Completed Phase 2
~80

Find a Location

Who is running the clinical trial?

HilleVaxLead Sponsor
3 Previous Clinical Trials
3,506 Total Patients Enrolled
3 Trials studying Gastroenteritis
3,506 Patients Enrolled for Gastroenteritis

Media Library

Open Arm Study Clinical Trial Eligibility Overview. Trial Name: NCT05972733 — Phase 2
Gastroenteritis Research Study Groups: Open Arm Study
Open Arm Study 2023 Treatment Timeline for Medical Study. Trial Name: NCT05972733 — Phase 2
Gastroenteritis Clinical Trial 2023: Open Arm Study Highlights & Side Effects. Trial Name: NCT05972733 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has the Open Arm Study received regulatory authorization from the FDA?

"Open Arm Study is assessed with a score of 2, as it has been through one stage of validation for safety but not yet established efficacy."

Answered by AI

Does the research include participants over 45 years of age?

"The prerequisites for participating in this trial necessitate that the patient be aged between 18 and 49 years. Additionally, there are 17 trials available for minors and 6 more specifically designed to assist those over 65."

Answered by AI

Could I be considered a potential participant in this research initiative?

"Eligibility for this clinical trial requires that the patient has gastroenteritis and is between 18 to 49 years old. The medical team are searching for 80 individuals who match these criteria."

Answered by AI

Are there any remaining vacancies for individuals to participate in this experiment?

"According to the available information on clinicaltrials.gov, this medical study has concluded its recruitment process and is no longer searching for participants. Originally posted on August 2nd 2023, it was last modified a month later; however, there are 22 other trials actively recruiting patients currently."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Serologic Assay Validation and Proficiency Testing of HIL-214 in Adults
2023. "Serologic Assay Validation and Proficiency Testing of HIL-214 in Adults". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05972733.
~48 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top